Robert Francomano

Insider Reports History

Entity
Individual
Location
C/O Stemline Therapeutics, Inc., 750 Lexington Avenue, 11 Th Floor, New York, NY
Signature
/s/ Robert Francomano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Francomano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SELLAS Life Sciences Group, Inc. Chief Commercial Officer Common Stock 40.9K $256K $6.25 Jan 22, 2024 Direct
SELLAS Life Sciences Group, Inc. Chief Commercial Officer Class A Common Stock 20.9K $22.6K $1.08 Dec 6, 2023 Direct
SELLAS Life Sciences Group, Inc. Chief Commercial Officer Stock Option (Right to Buy) 30K Jan 22, 2024 Direct

Insider Reports Filed by Robert Francomano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLS SELLAS Life Sciences Group, Inc. Jan 22, 2024 2 $0 4 Jan 25, 2024 Chief Commercial Officer
SLS SELLAS Life Sciences Group, Inc. Dec 6, 2023 1 -$1.17K 4 Dec 8, 2023 Chief Commercial Officer
SLS SELLAS Life Sciences Group, Inc. Feb 2, 2023 2 $0 4 Feb 3, 2023 Chief Commercial Officer
SLS SELLAS Life Sciences Group, Inc. Mar 14, 2022 1 $0 4 Mar 15, 2022 Chief Commercial Officer
SLS SELLAS Life Sciences Group, Inc. Mar 14, 2022 0 $0 3 Mar 14, 2022 Chief Commercial Officer